We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GAO Shines Spotlight on Dearth of Antibacterial and Antifungal Treatments, Despite Special Pathway Available to Developers
GAO Shines Spotlight on Dearth of Antibacterial and Antifungal Treatments, Despite Special Pathway Available to Developers
There aren’t enough drugs under development to treat antibacterial and antifungal infections in patients with limited treatment options, even though the FDA offers a particular pathway to help expedite such candidates, the Government Accountability Office (GAO) has reported.